Evidence map›Paper›PMID 33834875›Full record

ArticleJournal of investigative medicine high impact case reports

Primary Neuroendocrine Tumor of the Scrotum: An Uncommon Site for a Rare Tumor.

Komal Akhtar, Vrinda Vyas, Prashanth Ashok Kumar, James Corines, Gustavo de la Roza, Alina Basnet

Abstract readCase Reports
In one paragraph

Article in Journal of investigative medicine high impact case reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Komal AkhtarSUNY Upstate Medical University, Syracuse, NY, USA.
Vrinda VyasSUNY Upstate Medical University, Syracuse, NY, USA.
Prashanth Ashok KumarSUNY Upstate Medical University, Syracuse, NY, USA.ORCID 0000-0001-6236-2822
James CorinesSUNY Upstate Medical University, Syracuse, NY, USA.
Gustavo de la RozaSUNY Upstate Medical University, Syracuse, NY, USA.
Alina BasnetSUNY Upstate Medical University, Syracuse, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroendocrine tumors (NETs) are a heterogeneous group of tumors developing from neural crest cells, with numerous sites of origin, commonly the gastrointestinal and genitourinary tracts. NETs of the genitourinary tract are more common in women. Small cell carcinoma of the prostate or testicular carcinoid are the NETs in male. In this article, we present a rare case of NET of the scrotum. Our patient was a 47-year-old male with a history of complicated pilonidal cysts resulting in chronic scrotal wounds. Biopsy of a large nonhealing scrotal wound revealed a high-grade neuroendocrine carcinoma with features most suggestive of small cell carcinoma. Presenting with advanced disease at diagnosis, he was started on systemic therapy and unfortunately progressed through multiple lines of treatment, including CAPTEM (capecitabine and temozolomide). Unfortunately, due to multiple logistical reasons, the patient was unable to receive the then off-label immunotherapy based on DART (Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors) trial. He, unfortunately, succumbed to his disease within months of diagnosis.

Indexed as

Neuroendocrine TumorsScrotumAntineoplastic Combined Chemotherapy ProtocolsCapecitabineFemaleHumansMaleMiddle AgedTemozolomideCapecitabineTemozolomideneuroendocrine tumorscrotal carcinomascrotal malignancy

Identifiers

PMID33834875
PMCPMC8040611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.